Bharat Immunologicals & Biologicals Corporation Ltd Balance Sheet Annual

BSE: 524663 | NSE: - | ISIN: INE994B01014 | Sector: Biotechnology & Drugs

15.95 +0.20 (1.27%)Updated : 14 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2023	2022	2021	2020
Period End Date	Mar 23	Mar 22	Mar 21	Mar 20
Total Liabilities Shareholders' Equity	185.66	212.73	103.99	126.83
Cash Equivalents	1.29	4.64	1.23	0.99
Other Liabilities Total	6.42	6.11	5.85	5.65
Common Stock Total	43.18	43.18	43.18	43.18
Other Current Assets Total	9.02	15.04	9.92	11.59
Total Assets	185.66	212.73	103.99	126.83
Cash	7.45	8.37	9.31	11.11
Total Equity	87.80	105.35	34.04	20.47
Long Term Investments	9.28	9.06	12.52	13.63
Retained Earnings( Accumulated Deficit)	44.62	62.17	-9.14	-22.71
Total Common Shares Outstanding	4.32	4.32	4.32	4.32
Tangible Book Valueper Share Common Eq	20.33	24.40	7.88	4.74
Total Liabilities	97.86	107.38	69.94	106.36
Total Debt	70.22	77.89	27.29	3.04
Cashand Short Term Investments	8.74	13.01	10.54	12.10
Total Receivables Net	13.88	1.13	0.01	17.61
Notes Payable/ Short Term Debt	70.22	77.89	27.29	3.04
Accounts Receivable- Trade Net	13.88	1.13	0.01	17.61
Property/ Plant/ Equipment Total- Net	115.33	115.98	36.13	4.68
Total Current Liabilities	91.44	101.26	64.09	100.71
Total Inventory	1.43	36.25	13.49	51.72
Accounts Payable	0.48	0.87	14.79	43.53
Other Currentliabilities Total	20.74	22.51	22.00	54.14
Other Long Term Assets Total	27.27	21.48	20.54	14.51
Note Receivable- Long Term	0.71	0.78	0.85	0.98
period Length	0.00	0.00	0.00	0.00
Total Current Assets	33.06	65.43	33.95	93.02
Total Long Term Debt	-	0.00	0.00	0.00